Rie Horii

Summary

Affiliation: Cancer Institute Hospital
Country: Japan

Publications

  1. ncbi request reprint Spontaneous " healing" of breast cancer
    Rie Horii
    Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:140-4. 2005
  2. ncbi request reprint Muco-epidermoid carcinoma of the breast
    Rie Horii
    Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 56:549-53. 2006
  3. ncbi request reprint Assessment of hormone receptor status in breast cancer
    Rie Horii
    Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 57:784-90. 2007
  4. ncbi request reprint Histological features of breast cancer, highly sensitive to chemotherapy
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 14:393-400. 2007
  5. pmc Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
    R Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Br J Cancer 97:654-8. 2007
  6. doi request reprint Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:233-41. 2010
  7. doi request reprint Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes
    Ryoichi Matsunuma
    Department of Surgery, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Int J Radiat Oncol Biol Phys 83:845-52. 2012
  8. ncbi request reprint High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy
    Tomo Osako
    Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:1431-8. 2010
  9. ncbi request reprint Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer Sci 105:576-82. 2014
  10. doi request reprint Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    J Clin Oncol 26:3727-34. 2008

Detail Information

Publications33

  1. ncbi request reprint Spontaneous " healing" of breast cancer
    Rie Horii
    Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:140-4. 2005
    ..Healing is a phenomenon by which the intraductal component of breast cancer disappears and is replaced by fibrous tissue. Focally localized healing often prevents confirmation of the continuity of intraductal carcinoma...
  2. ncbi request reprint Muco-epidermoid carcinoma of the breast
    Rie Horii
    Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 56:549-53. 2006
    ..These histological features confirmed the diagnosis as muco-epidermoid carcinoma of the breast. This is the first report of muco-epidermoid carcinoma of the breast in Japan...
  3. ncbi request reprint Assessment of hormone receptor status in breast cancer
    Rie Horii
    Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 57:784-90. 2007
    ..When assessing hormone receptors of breast cancer in routine clinical settings, it is sufficient to determine the proportion of positive cells in the entire cancer area...
  4. ncbi request reprint Histological features of breast cancer, highly sensitive to chemotherapy
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 14:393-400. 2007
    ..To establish tailor-made therapy for breast cancer, we investigated the possibility of predicting chemotherapy sensitive cases based on pre-therapeutic histological features...
  5. pmc Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
    R Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Br J Cancer 97:654-8. 2007
    ..Endocrine monotherapy may be sufficient as adjuvant treatment in the intermediate-risk patients, in which only one risk factor was present without any metastatic involvement in lymph node...
  6. doi request reprint Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:233-41. 2010
    ....
  7. doi request reprint Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes
    Ryoichi Matsunuma
    Department of Surgery, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Int J Radiat Oncol Biol Phys 83:845-52. 2012
    ..The purpose of this study was to identify patient groups for whom PMRT may be indicated, focusing on varied locoregional recurrence rates depending on lymphatic invasion (ly) status...
  8. ncbi request reprint High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy
    Tomo Osako
    Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:1431-8. 2010
    ..To determine the highly sensitive and highly resistant subsets to cytotoxic chemotherapy, we evaluated predictive factors for pCR and PD to NAC, and assessed the similarities in these factors...
  9. ncbi request reprint Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer Sci 105:576-82. 2014
    ..More accurate application of SN biopsy is required for patients with a preoperative diagnosis of DCIS...
  10. doi request reprint Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    J Clin Oncol 26:3727-34. 2008
    ..A large and systematic study is needed to address these important issues...
  11. doi request reprint Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes
    Tomo Osako
    Division of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo 135 8550, Japan
    Eur J Cancer 49:1187-95. 2013
    ..We aim to reveal the usefulness of the OSNA assay regarding the prediction of non-SN metastasis...
  12. pmc Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 8:6. 2010
    ..The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate...
  13. doi request reprint Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications
    Rin Yamaguchi
    Department of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo 135 8550, Japan
    Hum Pathol 41:679-85. 2010
    ..The presence of high-grade spindle cells in metaplastic breast carcinoma may indicate aggressive behavior...
  14. doi request reprint Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    APMIS 116:923-30. 2008
    ..ER-beta1 itself, independent of ER-alpha expression and tamoxifen treatment, seems to have a tumor-suppressive effect, at least in apocrine carcinomas. Further study of ER-beta1 is desired to optimize breast cancer treatment...
  15. doi request reprint Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer Sci 104:453-7. 2013
    ..Patient follow-up is required to elucidate the prognostic impact of nodal metastasis and occult invasion...
  16. doi request reprint Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer 117:4365-74. 2011
    ..The authors compared the performance in intraoperative detection of sentinel lymph node metastases with OSNA assay using a whole lymph node versus routine frozen section (FS) histology with a 2 mm-sectioned lymph node...
  17. doi request reprint Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
    Yoshinori Ito
    Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research Breast Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan
    Cancer Sci 102:130-6. 2011
    ..However, this study suggests that a randomized phase II study is a robust tool for obtaining a rapid conclusion on the usefulness of biomarkers and could be the foundation for further large clinical trials...
  18. pmc Clear cell sarcoma of the neck which metastasized to the mammary gland
    Ippei Fukada
    Department of Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, and the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Case Rep Oncol 6:55-61. 2013
    ..These findings led to a diagnosis of metastasis of clear cell sarcoma to the mammary gland. This is the first report of clear cell sarcoma of the neck which metastasized to the mammary gland...
  19. doi request reprint Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma
    Yoshimi Ide
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 61:731-6. 2011
    ..The presence of IMP components was a significant predictive factor for nodal metastasis, even if it is detected in only a small proportion of the tumor...
  20. pmc Skin invasion and prognosis in node negative breast cancer: a retrospective study
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 6:10. 2008
    ..The impact of skin invasion in node negative breast cancer is uncertain...
  21. doi request reprint Histogenesis of metaplastic breast carcinoma and axillary nodal metastases
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto ku, Tokyo, Japan
    Pathol Int 59:116-20. 2009
    ..This suggested that the ductal component metastasized to the nodes and that epithelial-mesenchymal transition subsequently occurred within the nodes...
  22. doi request reprint Apocrine metaplasia of breast cancer: clinicopathological features and predicting response
    Akiko Ogiya
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, Japan
    Breast Cancer 17:290-7. 2010
    ..We thus considered that apocrine metaplasia (AM) might represent a predictive marker for breast cancer...
  23. ncbi request reprint Intraductal papilloma with bloody discharge from Montgomery's areolar tubercle examined by ductoscopy from the areola
    Takehiko Sakai
    Breast Pathology Section, Cancer Institute, Japanese Foundation for Cancer Research, 3 10 6, Ariake, Tokyo 135 8550, Japan
    Breast Cancer 13:104-6. 2006
    ..Although there are a few breast carcinomas that cause bloody discharge and eruption of areola, areolar preservation should be performed with the knowledge that disease may also involve the areola through the lactiferous ducts...
  24. doi request reprint Breast cancer associated with mammary hamartoma
    Masaya Kai
    Department of Breast Surgery, Cancer Institute Hospital, Koto ku, Tokyo, Japan
    Breast Cancer 19:183-6. 2012
    ..We describe a case of invasive ductal carcinoma arising in the mammary hamartoma during the follow-up period of a previously diagnosed hamartoma...
  25. pmc Proposal of a novel method for observing the breast by high-resolution ultrasound imaging: understanding the normal breast structure and its application in an observational method for detecting deviations
    Ayumi Izumori
    The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 20:83-91. 2013
    ..We elucidated the detailed histological architecture of the normal breast, information indispensable for diagnostic US of the breast...
  26. ncbi request reprint Carcinoma in a solitary intraductal papilloma of the breast
    Rin Yamaguchi
    Department of Pathology, Cancer Institute Hospital, Tokyo, Japan
    Pathol Int 59:185-7. 2009
    ..An additional partial mastectomy was performed after the lumpectomy but no carcinoma foci were noted in the excised tissue. Possible occurrence of cancerous change in solitary intraductal papilloma of the breast was suspected...
  27. ncbi request reprint Present state of and problems with core needle biopsy for non-palpable breast lesions
    Takuji Iwase
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo 135 8550, Japan
    Breast Cancer 13:32-7. 2006
    ....
  28. ncbi request reprint A case of carcinosarcoma of the breast
    Nahomi Tokudome
    Department of Breast Pathology, The Cancer Institute, 3 10 16 Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:149-53. 2005
    ..Such tumors are very rare, and there have been no detailed reports of recurrence patterns of carcinosarcoma. Here we report our pathological findings in detail...
  29. doi request reprint Therapeutic strategies for breast cancer based on histological type
    Futoshi Akiyama
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 16:168-72. 2009
    ..Histological diagnosis is also significant from the viewpoint of drug sensitivity, and it is important to maintain the accuracy of histological diagnosis...
  30. doi request reprint Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis
    Tomo Osako
    Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Histopathology 63:509-19. 2013
    ..However, differential markers have not yet been assessed systematically, and we aimed to identify and evaluate novel and existing markers...
  31. ncbi request reprint [Histological features of breast cancer as predictive factors for chemotherapy]
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research
    Nihon Rinsho 65:160-4. 2007
  32. ncbi request reprint High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer
    Masataka Sawaki
    Department of Medical Oncology, Cancer Institute Hospital and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
    Breast Cancer 13:172-8. 2006
    ..We have summarized a single-center experience involving IBC patients. Our objectives are to clarify molecular alterations of HER-2/neu and p53 in IBC and to investigate the prognostic factors...
  33. ncbi request reprint [Evaluation of hormone receptor in breast cancers and the prognosis]
    Yuko Date
    Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research
    Nihon Rinsho 65:555-8. 2007